Stock Rating Report for GENE

Ticker: 

Stock Information

Ticker GENE
Company Name Genetic Technologies Ltd
Current Price $4.00
Previous Close $4.00
Industry Biotechnology
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? No

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for GENE. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Genetic Technologies Ltd next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Genetic Technologies Limited operates as a life science company, specializing in the fields of genetics and genomics primarily in Australia. The company provides genetic testing services to human beings for disease susceptibility, parentage, individual identity, forensics, and sports performance- animals, such as dogs, horses, birds, alpacas, exotics, and zoo animals for parentage, pedigree, traits, and disease susceptibility- and plants for traits and disease susceptibility. It also offers canine reproductive services, as well as involves in licensing its non-coding DNA patents. In addition, the company offers BREVAGen, a diagnostic test that informs clinicians and patients about individual, non-familial, sporadic risk of breast cancer for women where a breast biopsy outcome is indeterminate. The company was formerly known as Duketon Goldfields N.L. and changed its name to Genetic Technologies Limited in August 2000. Genetic Technologies Limited was incorporated in 1987 and is based in Fitzroy, Australia.


Latest News

Tue, 21 Feb 2012 10:15:00 GMTGenetic Technologies Successfully Concludes Second Patent Infringement Suit in USA
Thu, 16 Feb 2012 10:15:00 GMTGenetic Technologies Receives CLIA Certificate of Compliance From Centers for Medicare and MedicAid Services, USA
Mon, 06 Feb 2012 18:00:00 GMTGenetic Technologies Executes Settlement and License Agreement With Eurofins STA Laboratories, Inc.
Tue, 31 Jan 2012 10:15:00 GMTGenetic Technologies Files Quarterly Activities Report and ASX Appendix 4C for Quarter Ended December 31, 2011
Thu, 26 Jan 2012 19:32:02 GMT8 Stocks Under $10 Ripping Higher
Fri, 16 Dec 2011 10:15:00 GMTGenetic Technologies Appoints Dr. Mel Bridges as Chairman
Sun, 11 Dec 2011 18:32:31 GMTThe Race to the $1,000 Genome
Thu, 08 Dec 2011 17:44:56 GMTSmart Money Picks: Biotech Stocks With Bullish Short Trends
Fri, 02 Dec 2011 18:04:11 GMTGENETIC TECHNOLOGIES LTD Financials
Thu, 01 Dec 2011 13:00:00 GMTGenetic Technologies Executes Settlement and License Agreement with AutoImmun Diagnostika GmbH
Wed, 30 Nov 2011 22:04:09 GMT[$$] Stocks in the Spotlight Wednesday
Wed, 30 Nov 2011 13:11:44 GMTCoverage initiated on Genetic Technologies by Ladenburg Thalmann
Wed, 23 Nov 2011 21:09:58 GMT5 High-Flying Small Caps: What To Expect In 2012
Mon, 25 Jul 2011 21:10:02 GMTMonday Sector Laggards: Hospital & Medical Practitioners, Biotechnology Stocks
Mon, 18 Jul 2011 19:52:37 GMT3 Stocks Shaking the Market
Tue, 12 Jul 2011 20:33:30 GMTWhoa! What Just Happened to My Stock?
Tue, 12 Jul 2011 12:57:26 GMTGenetic Technologies shares haled dut proposed capital raise
Wed, 25 May 2011 22:57:13 GMT3 Stocks Shaking the Market
Thu, 12 May 2011 16:55:13 GMTThe Best-Performing Biotech Stocks So Far This Year
News provided by Yahoo! Finance
Home | StockProphet | Top 100 Stocks | New Hot Stock Picks | Sector Analyzer | Industry Analyzer | Member's Area | FAQ | Contact Us | Privacy and Security
(C) Copyright CycleProphet, Inc.  All Rights Reserved.

*Past performance does not guarantee future results. CycleProphet makes no representations or warrants that just because a stock would have made a profit in the past, using CycleProphet buy recommendations or sell recommendations, it will make any profits in the future. It is possible that these same stocks will lose money in the future using the CycleProphet stock recommendations.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither CycleProphet nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the CycleProphet site, a user agrees not to redistribute the information found therein.

thinkorswim, Division of TD AMERITRADE, Inc. and CycleProphet are separate, unaffiliated companies and are not responsible for each other's services and products.